Get answers: Are sinus infections contagious? What causes them? How to Prevent viral, bacterial or fungal sinus infections and how long sinus infection last? Sinus Infection Signs and Symptoms include sore throat, plugged nose with thick mucous, pain in the face, headaches, fever and tiredness. Sinus Infections (Sinusitis or Rhinosinusitis), …
Read More »Get Rid of Hickeys on Neck, Lips, Chest Fast Overnight
Tips on how to get rid of hickeys fast overnight. Learn hickey removal methods with or without cream and how long hickey last. Hickies are painless red mark bruises on neck, lips, chest or back made by sucking and kissing passionately during love making. It commonly called love bite. But …
Read More »Tagrisso/osimertinib side effects, cost, dosage for lung cancer
Tagrisso/osimertinib side effects, cost, dosage for lung cancer.Tagrisso is marketed by Astra Zeneca Pharmaceuticals based in Wilmington, Delaware. FDA approves new pill Tagrisso/osimertinib to treat certain patients with non-small cell lung cancer on November 13, 2015. FDA has approved Tagrisso (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic …
Read More »Nucala/Mepolizumab Side effects, Cost, Dosage for Asthma
Nucala/Mepolizumab Side effects, Cost, Dosage for Asthma. Nucala is marketed by GSK. Nucala mepolizumab is approved by FDA on 4th November 2015.Nucala mepolizumab is an interleukin-5 adversary monoclonal antibody (IgG1 kappa) demonstrated for the extra support or add-on treatment of patients with serious eosinophilic asthma. Nucala is a physician recommended …
Read More »Yondelis/Trabectedin Side effects, Cost, Dosage for Leiomyosarcoma and Liposarcoma
Yondelis/Trabectedin Side effects, Cost, Dosage for Leiomyosarcoma and Liposarcoma.Yondelis is marketed by Janssen Products of Raritan, New Jersey. yondelis for Leiomyosarcoma and Liposarcoma. Yondelis/trabectedin is first approved by FDA on 23rd October 2015.Yondelis trabectedin is chemotherapy for the treatment of particular type of soft tissue sarcomas (STS) – liposarcoma and leiomyosarcoma – …
Read More »Strensiq/Asfotase Alfa Side effects, Cost, Dosage for Hypophosphatasia
Strensiq/Asfotase Alfa Side effects, Cost, Dosage for Hypophosphatasia. Strensiq is marketed by Alexion pharmaceuticals. Strensiq is approved by FDA on 23rd October 2015.Its active ingredient is asfotase alfa.Strensiq asfotase alfa is used as the initially endorsed treatment for perinatal, infantile and juvenile onset hypophosphatasia (HPP). HPP is an uncommon, hereditary, progressive, …
Read More »Imlygic/Talimogene Laherparepvec Side effects, Cost, Dosage for Melanoma
Imlygic/Talimogene Laherparepvec Side effects, Cost, Dosage for Melanoma, FDA approval, Mechanism, Clinical trials. Imlygic is marketed by BioVex Inc., a subsidiary of Amgen Inc. The U.S. Food and Drug Administration approved Imlygic (talimogene laherparepvec) on 27th October 2015, the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in the …
Read More »Paresthesias (Nerve damage) after Wisdom tooth extraction
Dental Paresthesias (Nerve damage) after wisdom tooth extraction is a surgery complication. Pain, numbness or sensitivity of lips, tongue, mouth or face could be symptoms of nerve damage from pulled wisdom tooth. Learn risk, chances, symptoms, damage recovery and signs of permanent nerve damaged from wisdom tooth extraction procedure. Paresthesia …
Read More »USA Health Care System Compared to other Countries
Compare health care system in USA to other OECD countries on quality and spending, as US healthcare system is exclusive among the innovative industrialized nations. The U.S does not need a uniform health system, has no worldwide health care coverage, as well as current laws mandating coverage is not yet …
Read More »Vraylar/cariprazine bipolar-schizophrenia treatment side effects, cost, dosage, uses
Vraylar/cariprazine bipolar disorder and schizophrenia treatment, side effects, cost, dosage, uses. Vraylar/cariprazine FDA approval, cariprazine negative symptoms, cariprazine clinical trials. The U.S. Food and Drug Administration approved Vraylar/cariprazine capsules to treat schizophrenia and bipolar disorder in adults on September 17, 2015. Vraylar is the brand name of drug cariprazine, rights are currently owned …
Read More »